20351102|t|Oral administration of a GSK3 inhibitor increases brain insulin-like growth factor I levels.
20351102|a|Reduced brain input of serum insulin-like growth factor I (IGF-I), a potent neurotrophic peptide, may be associated with neurodegenerative processes. Thus, analysis of the mechanisms involved in passage of blood-borne IGF-I into the brain may shed light onto pathological mechanisms in neurodegeneration and provide new drug targets. A site of entrance of serum IGF-I into the brain is the choroid plexus. The transport mechanism for IGF-I in this specialized epithelium involves the IGF-I receptor and the membrane multicargo transporter megalin/LRP2. We have now analyzed this process in greater detail and found that the IGF-I receptor interacts with the transmembrane region of megalin, whereas the perimembrane domain of megalin is required for IGF-I internalization. Furthermore, a GSK3 site within the Src homology 3 domain of the C-terminal region of megalin is a key regulator of IGF-I transport. Thus, inhibition of GSK3 markedly increased internalization of IGF-I, whereas mutation of this GSK3 site abrogated this increase. Notably, oral administration of a GSK3 inhibitor to adult wild-type mice or to amyloid precursor protein/presenilin 1 mice modeling Alzheimer amyloidosis significantly increased brain IGF-I content. These results indicate that pharmacological modulation of IGF-I transport by megalin may be used to increase brain availability of serum IGF-I. Interestingly, GSK3 inhibitors such as those under development to treat Alzheimer disease may show therapeutic efficacy in part by increasing brain IGF-I levels, an effect already reported for other neuroprotective compounds.
20351102	25	29	GSK3	Gene	56637
20351102	56	84	insulin-like growth factor I	Gene	16000
20351102	122	150	insulin-like growth factor I	Gene	16000
20351102	152	157	IGF-I	Gene	16000
20351102	214	241	neurodegenerative processes	Disease	MESH:D019636
20351102	311	316	IGF-I	Gene	16000
20351102	379	396	neurodegeneration	Disease	MESH:D019636
20351102	455	460	IGF-I	Gene	16000
20351102	527	532	IGF-I	Gene	16000
20351102	577	591	IGF-I receptor	Gene	16001
20351102	632	639	megalin	Gene	14725
20351102	640	644	LRP2	Gene	14725
20351102	717	731	IGF-I receptor	Gene	16001
20351102	775	782	megalin	Gene	14725
20351102	819	826	megalin	Gene	14725
20351102	843	848	IGF-I	Gene	16000
20351102	881	885	GSK3	Gene	56637
20351102	952	959	megalin	Gene	14725
20351102	982	987	IGF-I	Gene	16000
20351102	1019	1023	GSK3	Gene	56637
20351102	1062	1067	IGF-I	Gene	16000
20351102	1094	1098	GSK3	Gene	56637
20351102	1163	1167	GSK3	Gene	56637
20351102	1197	1201	mice	Species	10090
20351102	1208	1233	amyloid precursor protein	Gene	11820
20351102	1234	1246	presenilin 1	Gene	19164
20351102	1247	1251	mice	Species	10090
20351102	1261	1282	Alzheimer amyloidosis	Disease	MESH:D000686
20351102	1313	1318	IGF-I	Gene	16000
20351102	1386	1391	IGF-I	Gene	16000
20351102	1405	1412	megalin	Gene	14725
20351102	1465	1471	IGF-I.	Gene	16000
20351102	1487	1491	GSK3	Gene	56637
20351102	1544	1561	Alzheimer disease	Disease	MESH:D000544
20351102	1620	1625	IGF-I	Gene	16000
20351102	Association	14725	16000
20351102	Association	MESH:D019636	16000
20351102	Association	MESH:D000544	56637
20351102	Association	16000	56637
20351102	Association	14725	56637
20351102	Association	14725	16001
20351102	Association	16000	16001
20351102	Association	MESH:D000544	16000
20351102	Association	MESH:D000686	11820
20351102	Positive_Correlation	MESH:D000686	16000
20351102	Association	MESH:D000686	19164

